- HK$813.48m
- HK$1.18bn
- HK$1.64bn
Brief: China Medical & Healthcare Group Says FY Loss Attributable Hk$137.3 Mln
Brief: China Medical & Healthcare Sees An Increase In Loss Attributable For Year In Range Of About HK$130 Million To HK$190 Million
Brief: China Medical & Healthcare Group Says HY Loss Attributable HK$73.9 Mln
Brief: China Medical & Healthcare Says Normal Business Ops Of Nanjing Tongren Hospital Affected
Brief: China Medical & Healthcare Sees Decrease Of 76% In Loss Attributable For Four Months
Brief: China Medical & Healthcare Group Says Kong Muk Yin Ceased To Be An Executive Director
Brief: Hong Kong's Market Misconduct Tribunal Fines China Medical & Healthcare For Late Disclosure Of Inside Information
Brief: China Medical & Healthcare Group Sees FY Loss Attributable Between HK$100 Mln To HK$170 Mln
Brief: China Medical & Healthcare Sees Loss Attributable For Year In Range Of Hk$30 Mln To Hk$60 Mln
Brief: China Medical & Healthcare Group Says Pingan Dianchuang International Finance Leasing Co. To Buy Medical Equipments
Brief: China Medical & Healthcare Group Says Expects Loss Attributable For HY
Brief: China Medical & Healthcare Sees Decrease Of About 34% In Revenue For Qtr
Brief: China Medical & Healthcare Says it recorded fall in QTRLY Loss Attributable On Preliminary Basis
Brief: China Medical & Healthcare Says Chairman & Executive Director Got Decision On Disciplinary Measures
Brief: China Medical & Healthcare Sees Substantial Reduction In Loss Or Small Profit Attributable Of About Hk$1 Mln-Hk$13 Mln For 18 Months
Brief: China Medical & Healthcare Says Updates On Disclosure Proceedings By Securities & Futures Commission
Brief: Hong Kong's SFC Commences Market Misconduct Tribunal Proceedings Against China Medical & Healthcare Group
Brief: China Medical & Healthcare Group Sees Profit Attributable For Twelve Months Ended 30 June 2019
Brief: China Medical & Healthcare Group Announces Termination Of Cooperation Agreements